Indaptus Therapeutics, Inc. (INDP)

NASDAQ: INDP · IEX Real-Time Price · USD
4.81
-0.10 (-2.04%)
At close: Jan 25, 2022 4:00 PM
4.80
-0.01 (-0.21%)
After-hours:Jan 25, 2022 7:41 PM EST
Market Cap39.41M
Revenue (ttm)n/a
Net Income (ttm)-18.60M
Shares Out8.19M
EPS (ttm)-4.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40,006
Open4.73
Previous Close4.91
Day's Range4.72 - 4.96
52-Week Range4.46 - 36.80
Betan/a
AnalystsBuy
Price Target16.00 (+232.6%)
Earnings Daten/a

About INDP

Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's lead candidate is Decoy20 that is in pre-clinical stage to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma. It also develops ...

IndustryBiotechnology
Founded2000
CEOJeffrey Meckler
Employees1
Stock ExchangeNASDAQ
Ticker SymbolINDP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for INDP stock is "Buy" and the 12-month stock price forecast is 16.00.

Price Target
$16.00
(232.64% upside)
Analyst Consensus: Buy

News

Indaptus Therapeutics to Present at H.C. Wainwright BioConnect 2022 Virtual Conference

NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that Jeffrey Meckler, Chief Executive Officer, will participate in a...

2 weeks ago - GlobeNewsWire

Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer

Seasoned Drug Developer Brings More Than Twenty Years of Medical Leadership and Clinical Oncology Experience

3 weeks ago - GlobeNewsWire

Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announces financial results for the third quarter ended September 30, 2021 and...

2 months ago - GlobeNewsWire

Maxim Upgrades Indaptus Therapeutics To Buy

Maxim analyst has upgraded Indaptus Therapeutics Inc (NASDAQ: INDP) to Buy from Hold with a $16 price target, an upside of over 100%. Analyst Jason McCarthy says, Indaptus is leveraging the ability of a...

3 months ago - Benzinga

INDP Stock: The Patent News That Has Indaptus Therapeutics Skyrocketing Today

Shares of INDP stock are skyrocketing on Wednesday after the U.S. Patent and Trademark Office made a big move for Indaptus Therapeutics. The post INDP Stock: The Patent News That Has Indaptus Therapeuti...

4 months ago - InvestorPlace

Indaptus Therapeutics stock nearly triples on heavy volume after allowance for patent of platform technology

Shares of Indaptus Therapeutics Inc. INDP, +190.95% nearly tripled on massive volume in midday trading, to bounce off the previous session's record closing low, after the developer of treatments for hep...

4 months ago - Market Watch

Why Are Indaptus Therapeutics Shares Shooting Higher On Wednesday?

The United States Patent and Trademark Office has issued a notice of patent allowance to Indaptus Therapeutics Inc's (NASDAQ: INDP) platform technology. The patent provides broad protection for applying...

4 months ago - Benzinga

Indaptus Therapeutics Receives Notice of Allowance for Strategic Patent

Key Patent for Platform Technology to Treat or Inhibit HBV and HIV Infections Key Patent for Platform Technology to Treat or Inhibit HBV and HIV Infections

4 months ago - GlobeNewsWire

Intec Closes Merger with Decoy Biosystems

NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company," and formerly, Intec Parent, Inc.) today announced the closing of its previously announced ...

5 months ago - PRNewsWire

Intec Announces Expected Closing Date of Decoy Merger

JERUSALEM, Aug. 3, 2021 /PRNewswire/ -- Intec Parent, Inc. (NASDAQ: NTEC) ("Intec Parent" or the "Company"), today announced that the pending and previously announced reverse merger (the "Decoy Merger")...

5 months ago - PRNewsWire

NTEC Stock: 10 Things to Know About Red-Hot Intec Pharma

NTEC stock is riding high today without any news. It seems investors are getting hyped up ahead of its merger with Decoy Biosystems.

5 months ago - InvestorPlace

3 Biotech Penny Stocks To Watch On Robinhood IPO Day

These Former Penny Stocks Are Turning Heads Ahead Of Robinhood IPO The post 3 Biotech Penny Stocks To Watch On Robinhood IPO Day appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...

Other symbols:GTBPPAVM
5 months ago - PennyStocks

Intec Announces $30 Million Private Placement Ahead of Decoy Merger

JERUSALEM, July 26, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec Israel" or the "Company"), today announced that its wholly-owned subsidiary, Intec Parent, Inc. ("Intec US"), entered in...

5 months ago - PRNewsWire

Hot Penny Stocks to Buy Now? 4 You Need to Know About

These hot penny stocks may deserve a place on your watchlist this month The post Hot Penny Stocks to Buy Now? 4 You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information ...

Other symbols:GOEDNMTROGEN
6 months ago - PennyStocks

Best Penny Stocks To Buy Before Marijuana Legalization? 4 To Watch Now

Marijuana legalization is a hot topic & some penny stocks are benefiting in 2021. The post Best Penny Stocks To Buy Before Marijuana Legalization?

Other symbols:EASTEVGNOGI
6 months ago - PennyStocks

Top 10 Biotech Penny Stocks to Watch in July 2021

Are these the best biotech penny stocks to watch next month? Here's 5 more for your list The post Top 10 Biotech Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:ADILMNOVOPKVTVT
7 months ago - PennyStocks

Best Penny Stocks To Buy Now? 7 To Watch This Week

What are the best penny stocks to buy this week? The post Best Penny Stocks To Buy Now?

7 months ago - PennyStocks

Hot Reddit Penny Stocks to Buy? Check These 3 Out

Looking for Reddit penny stocks to buy? Check these 3 out The post Hot Reddit Penny Stocks to Buy?

Other symbols:ABEVCIDM
8 months ago - PennyStocks

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Intec Pharma Ltd. - NTEC

NEW YORK, March 26, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class A...

9 months ago - PRNewsWire

SHAREHOLDER ALERT: WeissLaw LLP Investigates Intec Pharma Ltd.

NEW YORK, March 22, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intec Pharma Ltd.  ("Intec" or the "Co...

10 months ago - PRNewsWire

Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K

JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31...

10 months ago - GlobeNewsWire

Intec Pharma and Decoy Biosystems Announce Merger Agreement

JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with Deco...

10 months ago - PRNewsWire

Intec Pharma News: Why NTEC Stock Is on Fire Today

Shares of NTEC stock are soaring on Wednesday after Intec Pharma announced a cannabinoid research collaboration with GW Pharma. The post Intec Pharma News: Why NTEC Stock Is on Fire Today appeared first...

1 year ago - InvestorPlace

Intec Pharma Reports Third Quarter 2020 Financial Results and Provides Corporate Update

JERUSALEM, Nov. 5, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the third quarter ended September 30, 2020 and provides a corpor...

1 year ago - PRNewsWire

Intec Pharma Announces New Research Collaboration Agreement with MSD

JERUSALEM, Oct. 8, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces it has entered into a new research collaboration agreement with MSD, the tradename of ...

1 year ago - PRNewsWire